A phase I study of tenofovir disoproxil fumarate (PMPA [phosphonomethoxypropyladenine]prodrug), a novel nucleotide analog reverse transcriptase inhibitor in children with HIV infection
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2007
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Adverse reactions
- 02 Jun 2007 New trial record.